Perfusion Computed Tomography Scan Imaging in Differentiation of Benign from Malignant Parotid Lesions

Abstract Introduction The most common site of salivary gland tumors is the parotid gland. Computed tomography (CT), magnetic resonance imaging (MRI), and sonography are imaging modalities to differentiate benign from malignant parotid tumors. Objective The aim of this study is the evaluation of the diagnostic value of perfusion CT for differentiating histological categorization of benign and malignant parotid tumors. Methods A total of 29 patients with parotid neoplasms were enrolled in this study. Mean age and all CT perfusion variables (gradient and permeability, blood flow [BF], blood volume [BV], mean transit time [MTT], permeability surface [PS], maximum intensity projection [MIP], time-density curve [TDC], and time to peak [TTP]) were compared among three groups (malignant tumors [MTs], Warthin's tumor [WT] and pleomorphic adenomas [PA]). Results The mean age of the patients was 55.9 ± 14.1 (26–77), and 15 of them were male (51.7%). Eleven lesions were PAs [37.9%], 8 lesions were WTs (27.6%0 and 10 lesions (34.5%) were MTs (6 acinic cell carcinomas [ACCs], 3 adenocystic carcinomas [AdCCs], and 1 mucoepidermoid carcinoma [MEC]). The mean age of the patients with WTs was 62 ± 7.5 years; 52 ± 14.2 for patients with Pas, and 55.2 ± 17.2 for those with MTs (p = 0.32). The mean MIP was 122.7 ± 12.2 in WT, while it was 80.5 ± 19.5 in PA, and 76.2 ± 27.1 in MTs (p < 0.001); The mean MIP for WT was higher than for PAs and MTs; the values of MTs and PAs were not statistically different. The average of BF, BV, and curve peak were higher in WTs in comparison with the other two groups, and curve time 2 and TTP were higher in PAs in comparison with MTs. Conclusion Based on this study, perfusion CT of the parotid gland and its parameters can distinguish between benign and malignant parotid masses.

[1]  A. Bag,et al.  Imaging of Inflammatory Disorders of Salivary Glands. , 2018, Neuroimaging clinics of North America.

[2]  S. Mukherji,et al.  State-of-the-Art Imaging of Salivary Gland Tumors. , 2018, Neuroimaging clinics of North America.

[3]  L. Smeele,et al.  Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. , 2017, Oral oncology.

[4]  E. Neri,et al.  Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings. , 2016, The British journal of radiology.

[5]  Wenjiao Zeng,et al.  Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions , 2016, Oncology letters.

[6]  A. Razek,et al.  Effect of Increasing the Sampling Interval to 2 Seconds on the Radiation Dose and Accuracy of CT Perfusion of the Head and Neck , 2014, Journal of computer assisted tomography.

[7]  A. Razek,et al.  Perfusion CT of head and neck cancer. , 2014, European journal of radiology.

[8]  Y Dong,et al.  Diagnostic value of CT perfusion imaging for parotid neoplasms. , 2014, Dento maxillo facial radiology.

[9]  A. Knopf,et al.  Multimodal ultrasonographic characterisation of parotid gland lesions--a pilot study. , 2012, European journal of radiology.

[10]  T. Vogl,et al.  CT perfusion measurements of head and neck carcinoma from single section with largest tumor dimensions or average of multiple sections: agreement between the two methods and effect on intra- and inter-observer agreement. , 2012, European journal of radiology.

[11]  J. Klatka,et al.  Head and neck cancer: Value of perfusion CT in depicting primary tumor spread , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[12]  A. Ozonoff,et al.  Prediction of Locoregional Control in Head and Neck Squamous Cell Carcinoma with Serial CT Perfusion during Radiotherapy , 2011, American Journal of Neuroradiology.

[13]  M. Mack,et al.  Perfusion CT of head and neck cancer: effect of arterial input selection. , 2011, AJR. American journal of roentgenology.

[14]  J. Klatka,et al.  Evaluation of cervical lymph nodes with CT perfusion in patients with hypopharyngeal and laryngeal squamous cell cancer , 2011, Polish journal of radiology.

[15]  A. Thomas,et al.  Differentiation of Parotid Gland Tumors with Contrast-Enhanced Ultrasound , 2009, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[16]  E. Neri,et al.  CT perfusion of head and neck tumors: how we do it. , 2010, AJR. American journal of roentgenology.

[17]  J. Klussmann,et al.  Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved , 2009, European Archives of Oto-Rhino-Laryngology.

[18]  T. Vogl,et al.  Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. , 2007, European journal of radiology.

[19]  H. Matsubara,et al.  Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. , 2007, Oncology reports.

[20]  李树荣,et al.  Correlation between CT perfusion and vascular endothelial growth factor in neoplasm of head and neck , 2007 .

[21]  Sun Yat-sen,et al.  Correlation between CT perfusion and vascular endothelial growth factor in neoplasm of head and neck , 2007 .

[22]  Qiang Yu,et al.  [Diagnostic value of CT perfusion for parotid gland tumors]. , 2005, Shanghai kou qiang yi xue = Shanghai journal of stomatology.

[23]  Zoran Rumboldt,et al.  Perfusion CT for head and neck tumors: pilot study. , 2005, AJNR. American journal of neuroradiology.